Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints

Targeted Oncology
M AlsinaJ Tabernero

Abstract

Gastric cancer (GC) is a major world-wide health problem. It is the third leading cause of death from cancer. The treatment of advanced GC by chemotherapy has limited efficacy. The addition of some targeted therapies like trastuzumab and ramucirumab have added a modest benefit, but only in human epidermal growth factor receptor 2 (ERBB2 or HER2)-positive patients and in the second-line setting, respectively. The development of new and effective therapeutic strategies must consider the genetic complexity and heterogeneity of GC; prognostic and predictive biomarkers should be identified for clinical implementation. Immune deregulation has been associated with some GC subtypes, especially those that are associated with virus infection and those with a high mutational rate. Different mechanisms to prevent immunologic escape have been characterized during the last years; in particular the PD-1/PD-L1 inhibitors pembrolizumab, avelumab, durvalumab and atezolizumab have shown early sign of efficacy. Therefore, immunotherapeutic strategies may provide new opportunities for GC patients. This review will discuss (1) the main characteristics of GC treatment, (2) the immune response in GC, and (3) the current status of immune-related strate...Continue Reading

References

Jul 14, 1978·Science·B Amorena, W H Stone
May 1, 1990·The Journal of Experimental Medicine·F TriebelT Hercend
Jan 1, 1981·Cancer·A B MillerA Winkler
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Mar 22, 1996·Science·D R LeachJ P Allison
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Deirdre O'MahonyJohn E Janik
Jan 4, 2008·The New England Journal of Medicine·David CunninghamUNKNOWN Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jan 21, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y-K KangP I McCloud
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael A CurranJames P Allison
Feb 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christy RalphFiona C Thistlethwaite
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Anna Dorothea WagnerWolfgang E Fleig
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 8, 2010·The Journal of Experimental Medicine·Kaori SakuishiAna C Anderson
Sep 25, 2010·Molecular Cell·Jennifer M DoylePatrick Ryan Potts
Mar 9, 2011·The Journal of Experimental Medicine·Li WangRandolph J Noelle
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter C Thuss-PatiencePeter Reichardt
Dec 24, 2011·Nature·Ira MellmanGlenn Dranoff
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jung Hun KangSe Hoon Park
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jul 10, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Takashi FukuyamaNoritada Kobayashi
Jan 16, 2013·Clinical & Developmental Immunology·Magali TermeJulien Taieb
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
Nov 2, 2013·Cancer Research·Brendan D CurtiAndrew D Weinberg
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Apr 2, 2014·The Journal of Experimental Medicine·Xiaozhou FanJames P Allison
Jul 9, 2014·Nature Reviews. Clinical Oncology·Ignacio MeleroHåkan Mellstedt

❮ Previous
Next ❯

Citations

Dec 15, 2017·Cancer Medicine·Nikolaos CharalampakisAmanda Psyrri
Mar 25, 2016·Oncotarget·Christine BögerChristoph Röcken
Sep 9, 2016·World Journal of Gastroenterology : WJG·Minyu WangAlex Boussioutas
Feb 10, 2017·Journal of Cancer Research and Clinical Oncology·Zhi-Hua ZhouXiu-Wu Bian
Mar 30, 2017·Expert Review of Clinical Pharmacology·Marta BonottoGiuseppe Aprile
Jun 5, 2020·OncoTargets and Therapy·Shanshan NieHongwei Lu
Jul 16, 2020·Gastroenterology Report·Xiaoli Zhang, Zui Pan
Oct 9, 2020·Pharmacogenomics·Khalil El Gharib, Hampig Raphael Kourie
Nov 17, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Markus MoehlerYung-Jue Bang
Jan 11, 2021·Pathology, Research and Practice·Jun XieLi Jin
Apr 2, 2021·Journal of Clinical Laboratory Analysis·Qiaolian LiQiang Chen
Aug 10, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jiangang SunYongshun Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.